The case for sucralfate: Is it still relevant?
Keywords:
sucralfate, peptic-ulcer disease, alternative indications
Abstract
Sucralfate is a well-known drug indicated for the treatment of peptic ulcer disease. Since the introduction of other acidsuppressing agents like histamine-2 receptor antagonists and proton pump inhibitors, the use of sucralfate for this indication declined. This article gives an overview of the properties of sucralfate, as well as other indications where it can be the drug of choice.
Published
2021-12-07
Issue
Section
Product Review
By submitting manuscripts to SAPA, authors of original articles are assigning copyright to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAPA for educational and research purposes without obtaining permission.
